KCL joins new project launched by European consortium to improve newborn health
The HYPIEND project consists of 14 partners from eight European countries
Read More
Tag: endocrine disruptors
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
- Ipsen announces new data on Dysport in neurological disease
